IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$672M
AUM Growth
+$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
266
New
Increased
Reduced
Closed

Top Buys

1
+$23.4M
2
+$15.9M
3
+$15.5M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$15.4M
5
RLMD icon
Relmada Therapeutics
RLMD
+$10.2M

Top Sells

1
+$29.5M
2
+$19.7M
3
+$18.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
5
CLDX icon
Celldex Therapeutics
CLDX
+$15.8M

Sector Composition

1 Healthcare 98.54%
2 Consumer Staples 0.23%
3 Financials 0.12%
4 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$3.1M 0.1%
+260,000
77
$3.08M 0.1%
135,360
-480,000
78
$3.04M 0.1%
126,815
79
$3.01M 0.1%
136,486
+15,000
80
$2.95M 0.1%
127,000
-100,000
81
$2.93M 0.1%
+77,493
82
$2.86M 0.1%
255,138
-382,956
83
$2.77M 0.09%
233,576
+16,008
84
$2.77M 0.09%
23,654
85
$2.73M 0.09%
699,750
+550,000
86
$2.71M 0.09%
312
+242
87
$2.68M 0.09%
+250,000
88
$2.61M 0.09%
250,000
+48,192
89
$2.57M 0.09%
181,941
+106,496
90
$2.56M 0.09%
951,400
91
$2.55M 0.09%
7,293
+458
92
$2.46M 0.08%
142,166
+33,833
93
$2.42M 0.08%
124,091
-50,000
94
$2.39M 0.08%
+5,000
95
$2.32M 0.08%
111,223
-425,698
96
$2.25M 0.08%
+17,000
97
$2.25M 0.08%
+200,000
98
$2.13M 0.07%
83
-26
99
$2.11M 0.07%
415,884
-130,000
100
$1.94M 0.07%
+124,599
2 3
4
5 6